PCI 7 November 2023, 15:44
Temax_Krautz
Owen Mumford 12 January 2022, 17:40

Current Edition

Nasal & Pulmonary Drug Development
Cormica Banner Ad – 24.02.2025
Novo Nordisk 20 March 2024, 11:21
Biosynth: Fri 4 October 2024, 10:42

Nemera reinforces its value proposition with a refreshing visual identity

More modern, our new brand identity truly embodies who we are, how we partner with our customers and ultimately the value we bring to millions of patients across the world through our drug delivery device solutions.

At Nemera, we have been successfully providing high-quality drug delivery device solutions to our customers and patients for years. We design and manufacture devices with the ultimate goal to improve patient outcomes and experience. We are passionately growing our business around the combination product value chain through our holistic offering. We partner with our customers in an agile manner to accelerate bringing their products to patients. As our business evolves, we are pleased to introduce our new visual identity that reflects this transformation.

“We are thrilled to launch our new identity that re-unites our purpose of putting patients first and our commitment of being a holistic and agile partner. Together, they tell the unique story of our heritage and where we are headed alongside our customers in the drug delivery devices industry,” says Marc Hämel, Nemera’s CEO

Different look. Same commitment.

Our website. A user-friendly, easy to navigate and content-rich website that not only tells our story but also helps understand how we support our customers with our products, services and capabilities. It also makes it easier to contact and work with us. Live the experience at www.nemera.net and our social media channels!

Our logo. Warm, friendly and forward-looking, our logo speaks to our open, inclusive and patient-centric ethos.

About Nemera
As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy.

We are a holistic partner and help our customers succeed in the sprint to market their combination products. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards. Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfill our mission.

Stoelzle Skyscraper: 27th November 2024
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
LBBOHLE, Thu 20 April 2023, 17:23
Nipro 14 March 2024, 11:35